Ubiquitin–proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells

被引:0
|
作者
Ceshi Chen
Xiaodong Sun
Qimei Ran
Keith D Wilkinson
T J Murphy
Jonathan W Simons
Jin-Tang Dong
机构
[1] Winship Cancer Institute,Department of Oncology and Hematology
[2] Emory University School of Medicine,Department of Biochemistry
[3] Emory University School of Medicine,Department of Pharmacology
[4] Emory University School of Medicine,Department of Urology and Program in Genetics and Molecular Biology
[5] Emory University School of Medicine,undefined
来源
Oncogene | 2005年 / 24卷
关键词
KLF5; degradation; ubiquitin; proteasome; cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Ubiquitin-mediated proteolysis plays a central role in controlling intracellular levels of essential regulatory molecules such as p53, cyclins, myc, BRCA1, HIF-1α, etc. The Kruppel-like factor 5 (KLF5) transcription factor regulates biological processes involved in carcinogenesis, angiogenesis, and smooth muscle cell differentiation. In carcinogenesis, KLF5's role has been indicated by frequent genetic deletion as well as functional studies. Here we show that KLF5 is an unstable protein with a short half-life. Destruction of KLF5 was prevented by each of the proteasome-specific inhibitors tested but not by an inhibitor for trypsin-like proteases and cysteine proteases or by a lysosome inhibitor in epithelial cells. Furthermore, KLF5 underwent ubiquitination, and deletion of a 56-amino-acid sequence adjacent to a known transactivation domain of KLF5 significantly reduced its ubiquitination and degradation. Interestingly, cancer cells appeared to be more active in KLF5 degradation than untransformed epithelial cells, yet their proteasome activity was not higher. These results suggest that KLF5 protein is degraded at least in part through ubiquitination–proteasome pathway, which may have become hyperactive for KLF5 in cancer cells.
引用
收藏
页码:3319 / 3327
页数:8
相关论文
共 50 条
  • [21] Correlation between Expression of KLF5 and ZEB1 Transcription Factor Genes in Pancreatic Cancer
    Zinovyeva, M. V.
    Nikolaev, L. G.
    Kondratyeva, L. G.
    Vinogradova, T. V.
    Sverdlov, E. D.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2018, 481 (01) : 219 - 221
  • [22] Oestrogen causes degradation of KLF5 by inducing the E3 ubiquitin ligase EFP in ER-positive breast cancer cells
    Zhao, Ke-Wen
    Sikriwal, Deepa
    Dong, Xueyuan
    Guo, Peng
    Sun, Xiaodong
    Dong, Jin-Tang
    BIOCHEMICAL JOURNAL, 2011, 437 : 323 - 333
  • [23] Conditional knockout mice demonstrate function of Klf5 as a myeloid transcription factor
    Shahrin, Nur Hezrin
    Diakiw, Sonya
    Dent, Lindsay A.
    Brown, Anna L.
    D'Andrea, Richard J.
    BLOOD, 2016, 128 (01) : 55 - 59
  • [24] THE ROLE OF THE KRUPPEL-LIKE TRANSCRIPTION FACTOR KLF5 IN FOREGUT DEVELOPMENT
    Dinulos, Mary Beth
    Garcia, Mirian
    Vallee, Stephanie
    Dugan, Sarah
    Lefferts, Joel
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2018, 176 (06) : 1513 - 1514
  • [25] Acetylation of KLF5 Alters the Assembly of p15 Transcription Factors in Transforming Growth Factor-β-mediated Induction in Epithelial Cells
    Guo, Peng
    Zhao, Ke-Wen
    Dong, Xue-Yuan
    Sun, Xiaodong
    Dong, Jin-Tang
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (27) : 18184 - 18193
  • [26] Hypoxia regulates epithelial transcription factor expression through activation of the ubiquitin-proteasome degradation pathway.
    Taylor, CT
    Colgan, SP
    GASTROENTEROLOGY, 2000, 118 (04) : A700 - A701
  • [27] Targeting Kruppel-Like Factor 5 (KLF5) for Cancer Therapy
    Gao, Yu
    Ding, Ye
    Chen, Haiying
    Chen, Haijun
    Zhou, Jia
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2015, 15 (08) : 699 - 713
  • [28] Kruppel-like transcription factor5 (KLF5) is required for adipocyte differentiation
    Oishi, Y
    Manabe, I
    Tobe, K
    Yamauchi, T
    Kadowaki, T
    Nagai, R
    CIRCULATION, 2003, 108 (17) : 199 - 199
  • [29] YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer
    Jiang, Dewei
    Qiu, Ting
    Peng, Junjiang
    Li, Siyuan
    Tala
    Ren, Wenlong
    Yang, Chuanyu
    Wen, Yi
    Chen, Chuan-Huizi
    Sun, Jian
    Wu, Yingying
    Liu, Rong
    Zhou, Jun
    Wu, Kongming
    Liu, Wen
    Mao, Xiaoyun
    Zhou, Zhongmei
    Chen, Ceshi
    CELL DEATH AND DIFFERENTIATION, 2022, 29 (06): : 1283 - 1295
  • [30] YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer
    Dewei Jiang
    Ting Qiu
    Junjiang Peng
    Siyuan Li
    Wenlong Tala
    Chuanyu Ren
    Yi Yang
    Chuan-Huizi Wen
    Jian Chen
    Yingying Sun
    Rong Wu
    Jun Liu
    Kongming Zhou
    Wen Wu
    Xiaoyun Liu
    Zhongmei Mao
    Ceshi Zhou
    Cell Death & Differentiation, 2022, 29 : 1283 - 1295